Please try another search
Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the 'long' context, investors will essentially be "buying high, but hoping to sell...
Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the 'long' context, investors will essentially be "buying high, but hoping to sell...
Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the 'long' context, investors will essentially be "buying high, but hoping to sell...
Momentum investing revolves around the idea of following a stock's recent trend in either direction. In the 'long' context, investors will be essentially be "buying high, but hoping to sell even...
Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the 'long' context, investors will essentially be "buying high, but hoping to sell...
AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) incurred loss from continuing operations of 60 cents per share in the fourth quarter of 2018 against earnings of 2 cents reported in the year-ago quarter....
CAE (CAE) came out with quarterly earnings of $0.22 per share, missing the Zacks Consensus Estimate of $0.25 per share. This compares to earnings of $0.22 per share a year ago. These figures are...
Hasbro, Inc. (NASDAQ:HAS) reported dismal fourth-quarter 2018 results, wherein both earnings and revenues missed the Zacks Consensus Estimate for the second successive quarter. Following the...
Assurant, Inc. (NYSE:AIZ) is slated to report fourth-quarter 2018 results on Feb 12, after the market closes. In the last reported quarter, the company delivered a positive surprise of...
Boot Barn (BOOT) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one...
Fidelity National Information Services (NYSE:FIS) is scheduled to release fourth-quarter 2018 earnings on Feb 12, before the opening bell. While the company’s earnings are expected to reflect...
CDW Corporation’s (NASDAQ:CDW) fourth-quarter 2018 non-GAAP earnings per share surged 34.4% year over year to $1.32 and also beat the Zacks Consensus Estimate of $1.20.Solid growth in earnings...
Investors might want to bet on Asterias Biotherapeutics (AST), as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which...
Investors might want to bet on Amtek (AME), as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of the most...
Omnicell, Inc. (NASDAQ:OMCL) delivered adjusted earnings per share (EPS) of 70 cents in fourth-quarter 2018, beating the Zacks Consensus Estimate of 67 cents.Adjusted earnings improved 27.3% from...